multipl reason encourag reiter ow rais pt
invest summari reiter overweight rate rais
pt share increas price-to-earnings multipl given
grow confid recoveri result exceed expect
beat top bottom line deliv better-than-expect organ revenu
growth organ growth acceler sequenti guidanc
impli acceler rais organ revenu growth guidanc
midpt vs flat previous reaffim ep guidanc
despit expect increment fx headwind think risk/
reward look compel earlier year trade
discount large-cap med-tech peer similar discount
begin year although current sale
ep growth profil peer think discount give credit
deserv progress made recoveri clear long
way go full recoveri risk remain exceed expect
thu far manag commentari grow increasingli posit believ
guidanc attain manag appropri manag
solid top- bottom-lin beat report solid top line revenu
organ beat factset consensu organ growth
sequenti acceler view posit
sustain revenu growth primari short-term goal believ
make progress get market growth report
ep beat consensu
encourag manag increasingli favor tone restor full
suppli manag happi progress toward restor full suppli
believ progress reflect result meet
goal restor full suppli came expect
revenu guidanc impli acceler organ constant currenc
growth lower full-year guidanc report top-lin growth
due lower-expect benefit fx expect fx
tailwind compar previous midpoint
guidanc impli cc growth higher previou guidanc
flat growth despit lower revenu guidanc reiter ep
guidanc believ necessari step investor
believ guidanc reason attain
 valuat pt base price-to-earnings ep estim
disclosur section may found page
sourc compani document factset cantor fitzgerald estim
exhibit comparison cantor estim
compani document factset cantor fitzgerald estim
inc million except per dilut inc million except per share current priorcurr priorp growth gener adminstr incom expens tax provis dilut share juli
zbh oper issu leadership uncertainti warrant discount peer
 said think zbh valuat could quickli rebound move toward histor
averag post coupl strong quarter rebuild investor confid price target
base price-to-earnings multipl ep estim
manufactur issu suppli constraint could persist resolut manufactur issu
north campu delay sever occas delay state goal
restor suppli end made signific progress
fda could take addit action fda conduct recent inspect found
observ said on-track remedi plan address old new
observ anticip fda could potenti issu warn letter take
action could neg affect zbh oper
may abl recaptur share lost meaning amount hip knee share
last two year histor share shift given year ten basi
point may abl recaptur share quickli lost
million except per share data
cost good sold
sell gener adminstr
incom incom tax
sell gener adminstr
sell gener adminstr
compani document cantor fitzgerald research
zimmer biomet headquart warsaw indiana found becam public compani august spun
bristol-my squibb june zimmer acquir biomet deal creat current zimmer biomet pure-
play orthoped compani knee revenu hip revenu make total compani sport medicin
extrem trauma spine dental sale
